Mar Lozano

Assessing the impact of COVID-19 on liver cancer management (CERO-19)

Sergio Muñoz, Víctor Sapena, Alejandro Forner et al. · JHEP Reports · 2021 · 67 citations · Full text

Medicine, Infectious Diseases, Oncology +14

Therapy with ombitasvir/paritaprevir/ritonavir plus dasabuvir is effective and safe for the treatment of genotypes 1 and 4 hepatitis C virus (<scp>HCV</scp>) infection in patients with severe renal impairment: A multicentre experience

Raquel Muñoz-Gómez, Diego Rincón, Adriana Ahumada et al. · Journal of Viral Hepatitis · 2016 · 42 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Prevalence and distribution of hepatitis C virus genotypes in Spain during the 2000‐2015 period (the <scp>GEHEP</scp> 005 study)

Antonio Aguilera, Daniel Navarro, Francisco Rodríguez‐Frias et al. · Journal of Viral Hepatitis · 2017 · 30 citations

Life Sciences, Infectious Diseases, Microbiology +16

Outcome of liver cancer patients with SARS‐CoV‐2 infection: An International, Multicentre, Cohort Study

Sergio Muñoz, Víctor Sapena, Alejandro Forner et al. · Liver International · 2022 · 21 citations · Full text

Medicine, Infectious Diseases, Oncology +16

International and multicenter real‐world study of sorafenib‐treated patients with hepatocellular carcinoma under dialysis

Álvaro Díaz‐González, Marco Sanduzzi‐Zamparelli, Leonardo Gomes da Fonseca et al. · Liver International · 2020 · 19 citations · Full text

Medicine, Oncology, Pharmacotherapy +17